Background
==========

Type 2 diabetes is a cause of poor health and early death that is spreading worldwide and exerting a fearsome human and economic toll \[[@B1],[@B2]\]. Prevention and control of diabetes requires a better understanding of its basic molecular causes. Type 2 diabetes is a heterogeneous disease arising from physiological dysfunction in the pancreas, skeletal muscle, liver, adipose and vascular tissue. Much of the heterogeneity of type 2 diabetes has a genetic basis. A full picture of the complex genetic architecture of diabetes has been elusive \[[@B3]-[@B7]\].

Among type 2 diabetes susceptibility genes few, if any, individual loci are expected to carry alleles of major effect explaining a substantial proportion of cases, although a few genes could have a substantial population effect but not give a strong genetic signal if the causal alleles were common and the increase in risk were modest \[[@B6],[@B7]\]. Such genes have proven hard to detect using linkage-based approaches, although recent rapid advances in genetic association methodologies have led to some successes. The P12A polymorphism in the gene encoding the peroxisome proliferator-activated receptor-g (*PPARG*) \[[@B7]\], the E23K polymorphism in the gene encoding the islet ATP-dependent potassium channel Kir6.2 (*ABCC8*-*KCNJ11*) \[[@B8]-[@B10]\] and common variants in the gene encoding the transcription factor 7-like 2 gene (*TCF7L2*) \[[@B11],[@B12]\] were all found using well-powered association mapping, and all have been reproducibly associated with diabetes in diverse samples at highly significant p-values.

Current gene discovery strategies have focused on coding regions, but regulatory variants also influence disease \[[@B11],[@B13],[@B14]\]. A comprehensive picture of diabetes genetics will require a wide and adequately dense search across coding and conserved non-coding genomic regions using an association analysis approach, where power is superior to linkage analysis when seeking common variants of modest effect \[[@B6]\]. Resources are now becoming available to perform such genome-wide association (GWA) studies of type 2 diabetes \[[@B15]-[@B18]\].

In this report we describe the Framingham Heart Study (FHS) Affymetrix 100K SNP genome-wide association (GWA) study resource for type 2 diabetes. This resource complements the several other large extant type 2 diabetes GWA studies in three major respects: it is population-based (not diabetes proband-based), studies two generations, and has decades of longitudinal, standardized, detailed follow-up. We describe results of a simple low p-value-based SNP selection strategy and an alternate novel SNP selection strategy that takes advantage of the unique FHS diabetes-related quantitative traits data. We use FHS 100K SNPs in an *in silico*replication analysis that tests the hypothesis that SNPs in LD with published causal variants in *PPARG*, *ABCC8*, *TCF7L2*, *CAPN10*, and *HNFa*are associated with diabetes and related quantitative traits.

Methods
=======

Study subjects
--------------

The study sample is described in the Overview *Methods*section \[[@B19]\]. With respect to diabetes-related traits, Offspring subjects provided genotypes and diabetes-related traits to the analyses, and Offspring parents from the Original FHS Cohort contributed genotypes for linkage analysis and FBAT statistics. Of 1,345 FHS subjects with 100K SNP data, 1,087 were Offspring and of these 560 were women, the mean age at exam 5 was 52 years, and the mean age at last follow-up was 59 years. Every study subject provided written informed consent at every examination, including consent for genetic analyses, and the study was approved by Boston University\'s Institutional Review Board.

Genotyping and annotation
-------------------------

Affymetrix 100K SNP and Marshfield STR genotyping are described in the Overview *Methods*section \[[@B19]\]. Genotype annotation sources are described in the Overview *Methods*section \[[@B19]\].

Diabetes phenotyping
--------------------

Diabetes and related quantitative traits have been ascertained at every FHS exam for every generation. Diabetes-related quantitative traits available in the FHS 100K resource are displayed in Table [1](#T1){ref-type="table"}. FPG data for the analyses came from all 7 Offspring exams, but the remainder of the data came from exam 5 (1991--94), when subjects without diagnosed diabetes underwent a 75 gram oral glucose tolerance test, or exam 7 (1998--2001), the most recent exam. We defined diabetes as chart-review-confirmed diabetes, new or ongoing hypoglycemic treatment for diabetes at any exam, or a FPG \> 125 mg/dl at two or more of the seven exams. Diabetes age-of-onset was defined as the subject\'s age at the exam at which diabetes was first identified. Among Offspring with diabetes, \>99% have type 2 diabetes \[[@B4]\]. Of the 1,083 Offspring with 100K genotypes and known diabetes status, 91 had diabetes. The mean age of onset of was 58 yr; through exam 7, 9.3% of diabetic subjects had developed diabetes by age 40 yr, 33.0% by age 50, 68.1% by age 60, and 99.7% by age 80.

###### 

Type 2 diabetes-related quantitative traits in 1087 Framingham Offspring Study subjects with 100K genotype data

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Trait**                                        **Number of traits**   **Offspring Exam Cycle**   **Cohort Exam Cycle**   **Adjustment \***             **Number with Genotype and Trait Levels †**
  ------------------------------------------------ ---------------------- -------------------------- ----------------------- ----------------------------- ---------------------------------------------
  Fasting plasma glucose (FPG)                     1                      5, 7                       \-                      age, age^2^age, age^2^, BMI   1,027

  Hemoglobin A1c (HbA1c)                           1                      5, 7                       \-                      age, age^2^age, age^2^, BMI   623

  28 yr time averaged FPG (tFPG)                   1                      1--7                       \-                      age, age^2^age, age^2^, BMI   1,087

  Fasting insulin                                  1                      5, 7                       \-                      age, age^2^age, age^2^, BMI   982

  Homeostasis model insulin resistance (HOMA-IR)   1                      5                          \-                      age, age^2^age, age^2^, BMI   980

  0--120 min insulin sensitivity (ISI_0-120)       1                      5                          \-                      age, age^2^age, age^2^, BMI   935

  Incident type 2 diabetes                         1                      1--7                       \-                      age, age^2^age, age^2^, BMI   91 with diabetes\
                                                                                                                                                           1,083 without diabetes

  Adiponectin                                      1                      7                          \-                      age, age^2^age, age^2^, BMI   828

  Resistin                                         1                      7                          \-                      age, age^2^age, age^2^, BMI   831
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\* Traits were modeled as log(trait value) in sex-specific models. Residuals from these models were tested as quantitative traits associated with SNP genotype, and ranked residuals were used in linkage analyses.

† For traits with data at both exams 5 and 7, numbers are given for subjects with data at exam 5

In this presentation we focus on six (three glucose and three insulin) primary Offspring diabetes-related quantitative traits. Glucose traits are fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c) measured at exam 5, and up to 28 yr time-averaged FPG (tFPG) level obtained from the mean of up to seven serial exams. Glucose traits included all subjects, including those with diabetes regardless of treatment, as these were the most informative subjects with respect to hyperglycemia. Subjects with diabetes had the highest glucose values when subjects were ranked with respect to any glucose trait; those on treatment had the highest values. The three insulin traits are fasting insulin, homeostasis model-assessed insulin resistance (HOMA-IR), and Gutt\'s 0--120 min insulin sensitivity index (ISI_0-120) measured at exam 5. Subjects with insulin-treated diabetes were removed from all insulin trait analyses, as we had no information on insulin dose and so measured insulin values were confounded by insulin treatment \[[@B20]-[@B22]\]. We also analyzed incident diabetes from first exam through last follow-up. We previously have described FHS laboratory methods for these diabetes-related quantitative traits \[[@B4],[@B23]-[@B25]\]. In addition to glucose and insulin traits, levels of adiponectin and resistin are available in the FHS dbGaP resource. Plasma adiponectin and resistin concentrations were measured using a commercial ELISA (R&D Systems, Minneapolis, MN); inter- and intra-assays CVs were 5.3%--9.6% for adiponectin and 7.6%--10.5% for resistin.

SNP prioritization
------------------

We used two approaches to prioritize SNPs potentially associated with diabetes or diabetes related traits. In the first, we simply ordered SNPs from lowest to highest p-value for association with one or more of the six primary glucose and insulin traits. We also ordered SNPs or Marshfield STRS by highest to lowest LOD score for linkage to one or more of the six primary traits, and present LOD scores \> 2.0. In an alternative SNP prioritization strategy, we selected SNPs associated with multiple-related traits. In this approach, we selected SNPs with consistent nominal associations (p \< 0.01 in GEE or FBAT) with all three glucose traits OR all three insulin-related traits OR (two glucose and two insulin traits). Among these we used extent of LD to select a non-redundant set of SNPs; when several were perfect proxies for each other (r^2^≥ 0.8) only one SNP was selected, based on the highest genotyping call rate.

Statistical analysis
--------------------

The general statistical methods for linkage and GWA analyses are described in the Overview *Methods*\[[@B19]\]. For diabetes-related quantitative traits we used additive GEE and FBAT models, testing associations between SNP genotypes and age-age^2^-sex-adjusted residual trait values. We kept 70,987 SNPs in the analyses that were on autosomes, had genotypic call rates ≥ 80%, HWE p ≥ 0.001 and MAF ≥ 10%.

We tested association of 100K SNPs with incident type 2 diabetes in two additional models using the same adjustment strategy. First, Martingale residuals were created to measure the age-of-onset of type 2 diabetes; residuals were analyzed with FBAT \[[@B26]\]. Individuals with lower values of this \'martingale residual\' trait developed diabetes at younger ages, and those with the highest values had been observed for the longest time without development of diabetes \[[@B27]\]. Second, we used a Cox proportional hazard survival analysis with robust covariance estimates in order to find SNPs associated with development of diabetes over all seven exams \[[@B28]\].

Results
=======

Diabetes-related quantitative traits available in the FHS 100K SNP resource are listed in Table [1](#T1){ref-type="table"} and posted on the NCBI web site \[[@B29]\]. Each trait is available as an age-age^2^-adjusted or age-age^2^-BMI-adjusted residuals from sex-specific models. In this analysis we only consider the age-age^2^-adjusted traits. Among these, the following were the primary traits used in this analysis: exam 5 fasting plasma glucose (FPG; n with data = 1,027; mean, SD 99, 24.7 mg/dl); exam 5 HbA1c (n = 623; 5.28, 0.9%); 28-year time averaged FPG (tFPG; n = 1,087; 98, 16.2 mg/dl); exam 5 fasting insulin (n = 982; 30.1, 16.4 uU/ml); exam 5 HOMA-IR (n = 980; 7.8, 7.3 units); and the 0--120 min insulin sensitivity index (ISI_0-120; n = 935; 26.1, 7.6 mg·l^2^/mmol·mU·min). Among 1,087 Offspring with 100K SNP data there were 91 cases of type 2 diabetes. Additional diabetes-related quantitative traits not used in this analysis but that are available in the FHS 100K SNP dbGaP resource include, at exam 7: FPG (n = 987; 103, 26 mg/dl); fasting insulin (n = 999; 15.8, 12.8 uU/ml); HOMA-IR (n = 969; 4.2, 4.1 units); HbA1c (n = 893; 5.59, 0.97%); resistin (n = 831; 14.5, 7.4 ng/dl); adiponectin (n = 828; 9.9, 6.2 ng/dl).

The six primary quantitative traits had significant associations with 415 SNPs in GEE models and 242 SNPs in FBAT models, using p-value \< 0.001, and only considering SNPs with call rate ≥ 0.80, HWE p-value ≥ 0.001, and MAF ≥ 10%. Additionally, there were 91 significant associations with incident diabetes in the survival analyses and 42 significant associations with age-of-onset in FBAT, representing 128 non-overlapping SNPs. The 25 SNPs with lowest p-values in GEE or FBAT models, and LOD scores \> 2.0 in linkage analyses, are displayed in Table [2](#T2){ref-type="table"}. After accounting for the overlap between sets of significant associations, 736 non-overlapping SNPs were identified by the p-value approach for SNP prioritization.

###### 

Twenty five lowest p-values from GEE and FBAT models and LOD scores \> 2 for 100K SNPs and FHS diabetes-related quantitative traits

  **No.**                                  **Trait**         **SNP**          **Chr**   **Physical position**   **GEE or Cox p-value**   **FBAT p-value**   **Known Genes**                   
  ---------------------------------------- ----------------- ---------------- --------- ----------------------- ------------------------ ------------------ --------------------------------- ---------------------------------
  **2a. Ordered by GEE p-value**                                                                                                                                                              
                                                                                                                                                                                              
  1                                        tFPG              rs2722425        8         40603396                0.00000002               0.0047             ZMAT4                             
  2                                        Incident DM       rs10497721       2         192739868               0.0000007                0.0346             TMEFF2                            
  3                                        Fasting Insulin   rs2877832        14        26870017                0.000002                 0.0770                                               
  4                                        HOMA-IR           rs2877832        14        26870017                0.000003                 0.0918                                               
  5                                        tFPG              rs10510634       3         30321972                0.000005                 0.0516                                               
  6                                        FPG               rs180730         4         122159395               0.000005                 0.0374             PRDM5                             
  7                                        tFPG              rs180730         4         122159395               0.000006                 0.0252             PRDM5                             
  8                                        tFPG              rs7731657        5         129971218               0.000007                 0.0015                                               
  9                                        HbA1c             rs10486607       7         28957729                0.000008                 0.0440             CPVL                              
  10                                       ISI_0-120         rs2066219        13        68428665                0.000009                 0.0245                                               
  11                                       FPG               rs2722425        8         40603396                0.000009                 0.0998             ZMAT4                             
  12                                       Incident DM       rs2195499        2         41778050                0.000011                 0.3860                                               
  13                                       Incident DM       rs830604         3         71673037                0.000014                 0.5914             FOXP1                             
  14                                       FPG               rs2377689        2         106924358               0.000017                 0.0015             ST6GAL2                           
  15                                       Incident DM       rs931567         3         31410581                0.000018                 0.0095                                               
  16                                       FPG               rs10494331       1         156395176               0.000019                 0.0369             APCS                              
  17                                       tFPG              rs7147624        14        64935378                0.000019                 0.0201             FUT8                              
  18                                       tFPG              rs931567         3         31410581                0.000019                 0.0189                                               
  19                                       Incident DM       rs10511182       3         102255525               0.000020                 0.0510                                               
  20                                       FPG               rs337112         5         122556671               0.000022                 0.0148                                               
  21                                       ISI_0-120         rs9319109        13        84510270                0.000025                 0.0048                                               
  22                                       HOMA-IR           rs1927384        13        101943751               0.000026                 0.0059                                               
  23                                       ISI_0-120         rs7139897        13        107879625               0.000026                 0.0033                                               
  24                                       HbA1c             rs721346         11        103242667               0.000027                 0.5054             PDGFD                             
  25                                       HOMA-IR           rs300703         2         229416                  0.000027                 0.1086             SH3YL1                            
                                                                                                                                                                                              
  **2b. Ordered by FBAT p-value**                                                                                                                                                             
                                                                                                                                                                                              
  1                                        HbA1c             rs7719971        5         119990475               0.0324                   0.00002                                              
  2                                        HOMA-IR           rs10425253       19        36038375                0.0005                   0.00002                                              
  3                                        HOMA-IR           rs10511886       9         31826555                0.0933                   0.00002                                              
  4                                        Incident DM       rs256962         5         114970610               0.0030                   0.00002            TICAM2                            
  5                                        Fasting Insulin   rs10494321       1         154721517               0.0029                   0.00002            KIRREL                            
  6                                        Incident DM       rs1549415        8         120252290               0.0332                   0.00002                                              
  7                                        FPG               rs6910169        6         112990680               0.0062                   0.00003                                              
  8                                        HbA1c             rs2400207        5         145360290               0.0305                   0.00003            SH3RF2                            
  9                                        HbA1c             rs991672         5         120002649               0.0272                   0.00003                                              
  10                                       ISI_0-120         rs633082         9         107992360               0.0068                   0.00004                                              
  11                                       tFPG              rs10496802       2         139478604               0.0172                   0.00004                                              
  12                                       FPG               rs7684538        4         96725483                0.0202                   0.00005            UNC5C                             
  13                                       Fasting Insulin   rs963328         1         209426056               0.2949                   0.00005            FLVCR                             
  14                                       Incident DM       rs2432961        8         120266196               0.0069                   0.00005                                              
  15                                       Incident DM       rs2468168        8         120238819               0.0426                   0.00006            COLEC10                           
  16                                       ISI_0-120         rs6594987        5         116256211               0.1298                   0.00006                                              
  17                                       HOMA-IR           rs10511885       9         31821043                0.1250                   0.00007                                              
  18                                       tFPG              rs10487976       7         122429976               0.0076                   0.00007            SLC13A1                           
  19                                       tFPG              rs2204295        7         122432041               0.0060                   0.00007            SLC13A1                           
  20                                       HbA1c             rs9325002        5         145406441               0.0295                   0.00007            SH3RF2                            
  21                                       HbA1c             rs1365371        8         129018405               0.0298                   0.00007                                              
  22                                       HOMA-IR           rs2020362        19        36033107                0.0016                   0.00009                                              
  23                                       Incident DM       rs1489092        3         76204196                0.0535                   0.00010                                              
  24                                       ISI_0-120         rs2942321        5         19365227                0.4753                   0.00010                                              
  25                                       ISI_0-120         rs10501828       11        94883857                0.0067                   0.00010                                              
                                                                                                                                                                                              
  **2c. LOD \> 2, Ordered by Lod Score**                                                                                                                                                      
                                                                                                                                                                                              
  **No.**                                  **Trait**         **SNP or STR**   **Chr**   **Physical position**   **Marshfield cM**        **Max LOD**        **Physical position**             
                                                                                                                                                                                              
                                                                                                                                                            **Lower bound where LOD = 1.5**   **Upper bound where LOD = 1.5**
                                                                                                                                                                                              
  1                                        FPG               rs1890843        1         207225242               230.9                    3.64               205357346                         209935673
  2                                        HbA1c             rs1463697        3         195278503               217.5                    3.16               191762568                         197963623
  3                                        HOMA-IR           rs10513843       3         190998205               209.4                    3.08               188644318                         193634077
  4                                        Fasting insulin   rs4803953        19        51650847                70.1                     2.98               43726908                          56203682
  5                                        HbA1c             rs10510060       10        121853460               139.9                    2.41               119524854                         125827901
  6                                        HOMA-IR           rs10500300       19        53439815                73.3                     2.36               42063572                          57117898
  7                                        tFPG              rs2837076        21        39850406                38.7                     2.36               34879124                          41000937
  8                                        HbA1c             rs10497392       2         174176465               177.5                    2.30               153549351                         177629785
  9                                        tFPG              rs876362         2         80327060                102.6                    2.29               70585709                          112151653
  10                                       Fasting insulin   rs10513860       3         191902243               212.8                    2.21               187447466                         196384998
  11                                       FPG               rs1882347        2         164233821               167.3                    2.20               146837297                         171264176
  12                                       FPG               rs10512296       9         102073227               108.4                    2.15               91062454                          107815119
  13                                       tFPG              ATA20G07         5         180431                  0.0                      2.10               180431                            2855065
  14                                       tFPG              rs2444962        15        31214059                24.7                     2.05               23732660                          35462954
  15                                       HbA1c             rs10494382       1         159838765               175.2                    2.03               157467831                         200055293

The FHS has multiple measures of diabetes-related quantitative traits. We used a multiple-related trait approach in a strategy different from prioritizing SNPs based solely on small p-values. This approach yielded 203 SNPs associated with multiple traits. Of these, 53 were also associated with incident diabetes (p \< 0.01 by GEE or FBAT). We defined redundant SNPs as those in LD with *r*^2^\>= 0.80 to select 168 non-redundant SNPs associated with multiple traits; 42 of these non-redundant SNPs also were associated with incident diabetes (Table [3](#T3){ref-type="table"}). Examination of the multiple trait-based approach revealed 1) consistent associations of traits with SNPs that were in LD (providing reassurance that the signal was due to an association of traits with a particular genomic region rather than to technical error); 2) several putative associations of traits with SNPs in the same gene but not in perfect LD (suggesting that the association signal may be due to a functional role of that gene rather than a statistical fluctuation); and 3) associations of traits with SNPs in a variety of novel but plausible biological candidate genes.

###### 

Forty two (42) SNPs associated with (FPG, HbA1c, and tFPG) OR (fasting insulin, HOMA-IR, and ISI_0-120) OR (any two of either) AND incident DM

  **No.**   **Chr**   **SNP**      **N other SNPs with r^2^\> 0.8**   **Minor Allele A/G/T/C**   **MAF**   **Gene \***   **Gene Position**   **GEE Mean p-value**   **FBAT Mean p-value**   **Cox p-value**   **Minor Allele Cox HR for DM**   **FBAT DM Incidence p-value**          
  --------- --------- ------------ ---------------------------------- -------------------------- --------- ------------- ------------------- ---------------------- ----------------------- ----------------- -------------------------------- ------------------------------- ------ --------
  1         12        rs1368254    135                                G                          48.3%     *LOC387882*   Near                0.02                   0.001                   0.01              0.007                            0.007                           0.67   0.0008
  2         12        rs10506806   76                                 T                          29.7%                   Out                 0.003                  0.03                    0.01              0.01                             0.02                            0.65   0.004
  3         2         rs10496417   74                                 A                          34.5%     *SLC5A7*      Near                0.01                   0.003                   0.04              0.02                             0.007                           1.58   0.11
  4         8         rs10503835   8                                  C                          21.9%     *HMBOX1*      In                  0.004                  0.03                    0.03              0.008                            0.005                           0.59   0.03
  5         5         rs459743     83                                 C                          16.9%                   Out                 0.009                  0.009                   0.03              0.02                             0.002                           0.42   0.012
  6         10        rs1879316    55                                 A                          13.5%     *RASGEF1A*    Near                0.004                  0.001                   0.18              0.07                             0.009                           0.45   0.48
  7         13        rs2066219    79                                 G                          23.0%                   Out                 0.005                  0.0009                  0.22              0.08                             0.009                           0.59   0.22
  8         7         rs10487974   11                                 A                          36.9%     *SLC13A1*     Near                0.02                   0.08                    0.002             0.02                             0.001                           0.58   0.001
  9         3         rs1878175    54                                 G                          11.2%                   Out                 0.003                  0.003                   0.39              0.02                             0.003                           0.36   0.12
  10        3         rs697957     32                                 T                          25.2%     *CD47*        Near                0.005                  0.03                    0.03              0.03                             0.001                           1.65   0.02
  11        1         rs952635     9                                  G                          31.3%     *PDE4B*       In                  0.0007                 0.009                   0.06              0.41                             0.001                           0.56   0.16
  12        3         rs10512839   77                                 C                          25.9%     *CPNE4*       In                  0.02                   0.02                    0.05              0.009                            0.000                           1.78   0.03
  13        12        rs4767161    84                                 A                          13.3%     *RBM19*       In                  0.19                   0.05                    0.01              0.002                            0.15                            0.63   0.0014
  14        2         rs1073893    27                                 A                          17.7%     *FLJ32745*    In                  0.008                  0.16                    0.003             0.06                             0.18                            0.75   0.0008
  15        16        rs10500547   133                                G                          16.3%     *AB051533*    In                  0.07                   0.06                    0.03              0.003                            0.21                            1.29   0.002
  16        3         rs1489100    29                                 G                          41.0%                   Out                 0.01                   0.06                    0.004             0.16                             0.09                            0.75   0.0015
  17        2         rs2367204    73                                 G                          47.4%     *IMMT*        In                  0.007                  0.006                   0.27              0.05                             0.001                           1.58   0.03
  18        4         rs10489088   71                                 C                          12.7%                   Out                 0.24                   0.22                    0.01              0.001                            0.35                            1.22   0.005
  19        20        rs6093416    86                                 A                          14.0%     *TOP1*        Near                0.01                   0.003                   0.22              0.12                             0.00                            0.35   0.02
  20        5         rs871853     14                                 G                          41.5%     *CPLX2*       In                  0.10                   0.68                    0.001             0.02                             0.36                            1.15   0.0003
  21        7         rs1355037    156                                C                          23.4%     *ZPBP*        In                  0.29                   0.07                    0.05              0.001                            0.32                            1.18   0.006
  22        8         rs4418368    82                                 T                          36.1%     *DLGAP2*      In                  0.08                   0.08                    0.03              0.008                            0.27                            1.18   0.004
  23        4         rs10516471   26                                 G                          43.6%     *PPP3CA*      In                  0.006                  0.12                    0.02              0.10                             0.04                            0.70   0.007
  24        17        rs2322969    158                                C                          46.6%                   Out                 0.18                   0.006                   0.08              0.02                             0.04                            1.34   0.003
  25        4         rs1395114    28                                 A                          19.3%     *BX537758*    In                  0.004                  0.17                    0.01              0.22                             0.001                           1.79   0.02
  26        7         rs711517     88                                 G                          18.4%                   Out                 0.02                   0.008                   0.26              0.05                             0.000                           1.86   0.17
  27        10        rs332148     80                                 T                          18.5%     *WAC*         In                  0.02                   0.01                    0.18              0.09                             0.004                           0.46   0.03
  28        16        rs2042389    136                                T                          32.9%                   Out                 0.10                   0.17                    0.07              0.002                            0.003                           1.54   0.05
  29        16        rs7186570    90                                 G                          17.2%     *A2BP1*       In                  0.34                   0.12                    0.01              0.008                            0.91                            1.03   0.005
  30        8         rs9297181    36                                 A                          19.4%                   Out                 0.18                   0.08                    0.004             0.08                             0.25                            0.79   0.003
  31        18        rs540128     85                                 A                          36.2%     *PHLPP*       In                  0.38                   0.13                    0.02              0.005                            0.83                            0.97   0.004
  32        14        rs1954673    78                                 A                          26.4%                   Out                 0.005                  0.008                   0.35              0.43                             0.005                           0.56   0.63
  33        10        rs10509923   154                                C                          33.0%     *CSPG6*       Near                0.18                   0.002                   0.42              0.03                             0.008                           0.64   0.20
  34        5         rs861085     35                                 T                          30.6%     *NUDT12*      Near                0.008                  0.48                    0.01              0.28                             0.001                           0.52   0.02
  35        1         rs7531174    33                                 C                          20.6%     *SLC44A3*     In                  0.001                  0.21                    0.09              0.68                             0.001                           1.72   0.09
  36        7         rs6949530    57                                 T                          18.8%     *TAS2R16*     Near                0.67                   0.83                    0.007             0.005                            0.96                            0.99   0.009
  37        5         rs2967017    137                                T                          45.1%                   Out                 0.65                   0.15                    0.06              0.003                            0.82                            1.04   0.007
  38        3         rs729511     159                                A                          43.8%     *SLC9A9*      In                  0.45                   0.003                   0.14              0.13                             0.03                            0.70   0.008
  39        9         rs1060586    155                                T                          49.3%     *RBM18*       Near                0.16                   0.0008                  0.67              0.28                             0.00                            1.60   0.99
  40        17        rs2190706    157                                T                          34.2%                   Out                 0.48                   0.04                    0.20              0.007                            0.00                            1.55   0.03
  41        3         rs509208     31                                 C                          16.8%                   Out                 0.002                  0.06                    0.64              0.53                             0.01                            0.51   0.63
  42        10        rs7089102    87                                 G                          47.2%                   Out                 0.04                   0.006                   0.71              0.49                             0.01                            1.48   0.86

\* Gene symbol and position from UCSC Genome Browser (<http://genome.ucsc.edu/>; accessed September 2006); SNPs within 60 kb of a known gene are considered \'Near\'.

We used the UCSC Genome Browser (<http://genome.ucsc.edu/>; accessed September 2006) to annotate SNP details \[[@B30],[@B31]\]. Of the 823 (736 + 203; 116 overlapped) SNPs identified by both prioritization methods without removing SNPs in LD (*r*^2^\>= 0.80), 304 (36.9%) were in genes, 173 (21%) were within 60 kb of a known gene and 5 (0.61%) were coding. For comparison, of the 70,987 SNPs included in this analysis, 25,916 (36.5%) were in genes, 14,333 (20.2%) were within 60 kb of a known gene and 421 (0.59%) were coding.

Some SNPs had p-values \< 0.001 overlapping more than one analytical method. For instance, 18 SNPs were associated at p \< 0.001 with at least one quantitative trait in both the GEE and the FBAT analyses. For incident diabetes, 5 SNPs were associated with diabetes survival in the Cox models and with age-of-onset in the FBAT analyses.

We used the FHS 100K array data to verify, *in silico*, replicated associations of reported diabetes candidate genes (Table [4](#T4){ref-type="table"}). We found 7 SNPs in or near *TCF7L2*. One 100K SNP (rs7100927) was in moderate LD (r^2^= 0.5) with *TCF7L2*-associated SNP rs7903146 and was nominally associated with a 56% increased relative risk of diabetes (p = 0.007) and with tFPG (GEE p = 0.03). We found 6 SNPs in or near *ABCC8*, but no SNPs in strong LD with *ABCC8*A1369S (rs757110) or *KCNJ11*E23K (rs5219), and thus could not replicate these associations. One 100K SNP (rs878208) \~25 kb upstream of *ABCC8*showed nominal association with risk of diabetes, but it was not in LD with rs757110 in *ABCC8*(r^2^= 0.04). We found 15 SNPs in or near *PPARG*, but none were associated with diabetes. Four SNPs were associated (p \< 0.05) with quantitative traits but were not in LD (r^2^\< 0.03) with *PPARG*P12A (rs1801282), the variant previously associated with type 2 diabetes \[[@B7]\]. We found no polymorphic (MAF \> 1%) 100K SNPs in, near, or in LD with *CAPN10*or *HNFA*.

###### 

FHS 100K SNP Test of Association with SNPs in Established Candidate Genes for Type 2 Diabetes

  **Candidate Gene**   **Candidate SNP**   **Physical Position**   **FHS 100K SNP**   **Physical Position**   **r**^2^   **GEE lowest p-value**   **GEE Trait**     **FBAT Lowest p-value**   **FBAT Trait**    **Cox p-value**   **Cox HR for DM**
  -------------------- ------------------- ----------------------- ------------------ ----------------------- ---------- ------------------------ ----------------- ------------------------- ----------------- ----------------- -------------------
  ***ABCC8***          rs757110            17375053                rs878208           17478662                0.04       **0.05**                 Fasting insulin   0.12                      Fasting insulin   **0.02**          1.96
                                                                   rs722341           17429722                0.05       0.11                     tFPG              **0.009**                 HbA1c             0.70              1.09
                                                                   rs916829           17397049                0.02       0.18                     Fasting insulin   **0.02**                  Fasting insulin   0.47              0.84
                                                                   rs2283257          17446021                0.03       0.23                     ISI_0-120         0.05                      ISI_0-120         0.98              0.99
                                                                   rs2299641          17397566                0.01       0.38                     Fasting insulin   0.21                      ISI_0-120         0.19              1.24
                                                                   rs2190454          17490211                0.01       0.35                     Fasting insulin   0.25                      ISI_0-120         0.48              0.90
  ***PPARG***          rs1801282           12368125                rs10510422         12505413                0.00       **0.003**                tFPG              0.13                      ISI_0-120         0.13              3.86
                                                                   rs3856808          12505184                0.00       **0.005**                tFPG              0.17                      ISI_0-120         0.11              0.25
                                                                   rs10510421         12502242                0.00       **0.006**                tFPG              0.14                      ISI_0-120         0.12              0.26
                                                                   rs2938392          12409608                0.03       **0.007**                Fasting insulin   0.14                      Fasting insulin   0.36              1.13
                                                                   rs709157           12526881                0.00       0.05                     ISI_0-120         0.10                      ISI_0-120         0.68              0.93
                                                                   rs10510418         12363563                0.04       0.07                     Fasting insulin   0.10                      ISI_0-120         0.46              0.89
                                                                   rs1801282          12368125                **1.00**   0.07                     ISI_0-120         0.20                      HbA1c             0.89              0.96
                                                                   rs1899951          12369840                **1.00**   0.11                     ISI_0-120         0.25                      HbA1c             0.86              0.96
                                                                   rs4135268          12525199                0.01       0.11                     ISI_0-120         0.20                      tFPG              0.80              0.92
                                                                   rs10510417         12352294                0.31       0.17                     ISI_0-120         0.45                      ISI_0-120         0.62              0.91
                                                                   rs2292101          12409901                0.00       0.19                     tFPG              0.22                      Fasting insulin   0.08              1.62
                                                                   rs10510419         12401936                0.01       0.26                     tFPG              0.35                      ISI_0-120         0.24              1.31
                                                                   rs10510410         12321738                0.31       0.38                     FPG               0.36                      Fasting insulin   0.88              0.97
                                                                   rs10510411         12321849                0.31       0.40                     FPG               0.39                      Fasting insulin   0.94              0.99
                                                                   rs10510412         12321962                0.31       0.44                     FPG               0.38                      Fasting insulin   0.84              1.03
                       rs12255372\*        114798892               rs10509967         114685922               0.00       **0.04**                 HbA1c             0.12                      ISI_0-120         0.82              0.96
  ***TCF7L2***         rs7903146\*         114748339               **rs7100927**      **114786038**           **0.50**   **0.03**                 **tFPG**          **0.13**                  **tFPG**          **0.007**         **1.56**
                                                                   rs10509966         114666170               0.00       **0.04**                 HbA1c             0.07                      ISI_0-120         0.64              1.09
                                                                   rs10509969         114903549               0.08       0.14                     Fasting insulin   0.08                      FPG               0.60              0.89
                                                                   rs290483           114905204               0.10       0.17                     Fasting insulin   0.34                      tFPG              0.93              0.99
                                                                   rs7917983          114722872               0.09       0.27                     tFPG              0.29                      HbA1c             0.17              0.82
                                                                   rs10509970         114904903               0.05       0.32                     tFPG              0.43                      tFPG              0.51              1.14

\* LD betweaen rs12255372 and rs7903146 in HapMap CEU: *r*^2^= 0.78; Bold = r^2^\>= 0.5 or p-value \< 0.05

We also assessed our approach for confirmation of 4 SNPs associated with FPG reported on the Boston University Department of Genetics and Genomics public site <http://gmed.bu.edu/about/index.html> that displays selected associations with FHS 100K data. We found no association (all p-values \> 0.6) of incident diabetes or levels of FPG with SNPs rs10495355, rs9302082, rs10483948, or rs1148509.

Discussion and conclusion
=========================

In this paper we describe the characteristics and initial GWA results for type 2 diabetes and related quantitative traits in the FHS 100K SNP resource. Over 1000 men and women from a community-based sample have detailed linkage and association of diabetes-related phenotypes and 100K dense array SNP results available on the web. About 0.3%--0.6% of SNPs in the 100K array with MAF \> 10% are associated at p \< 0.001 with six diabetes-related quantitative traits or with incident type 2 diabetes. A similar proportion of SNPs in the array (0.21%) are associated with multiple related diabetes traits. These several hundred SNPs likely contain more false positive than true positive associations with diabetes and related traits, however, they offer logical next targets for the follow-up replication studies in independent samples necessary to resolve true diabetes risk genes. The FHS 100K data replicate the otherwise widely-replicated *TCF7L2*association with diabetes \[[@B11],[@B12],[@B32]-[@B40]\] in an *in silico*analysis.

The FHS 100K SNP data resource has potential value to detect and replicate novel type 2 diabetes susceptibility genes. The 100K SNP array is limited by relatively sparse coverage in some regions, accounting on average for just 30%--40% of the human genome in whites \[[@B17],[@B41]\]. Association with the risk SNP in *TCF7L2*is detectable at p \< 0.05, but there are no SNPs in adequate LD with *ABCC8*or *PPARG*to assess replication of causal SNPs in these accepted diabetes susceptibility genes. Thin coverage will be remedied to a large degree by the incipient availability in FHS of Affymetrix 500 k SNP array data as part of the planned FHS SHARe Study. (<http://www.nhlbi.nih.gov/meetings/nhlbac/sept06sum.htm>; accessed September 2006) Our analysis also demonstrates that true positive diabetes susceptibility gene signals are likely to be associated with modest p-values and will remain challenging to detect at the stringent p-values required for GWA studies. The enormous datasets generated by GWA scans have the potential to greatly advance understanding, or conversely to overwhelm the field with false leads. SNP prioritization strategies that leverage the complexity of the diabetes phenotype may offer some advantages over strictly p-value driven approaches. Replication, fine mapping, and functional studies are required to determine which approaches are most efficient and which SNPs are true positive diabetes risk factors. Integration with other GWA scans in similar cohorts will allow *in silico*replication of significant findings, increase power and reveal generalizability.

This report details the FHS contribution to publicly available diabetes-related genetic data. An important key to efficiently and economically achieving adequate power to detect association will be to integrate information from several GWA scans. While several cohorts have been assembled to perform GWA scans in type 2 diabetes, few possess the wealth of longitudinal, multigenerational phenotypic data available in Framingham. The FHS complements extant type 2 diabetes GWA studies. This report guides the way to harness the power of the FHS 100K SNP GWA resource to identify type 2 diabetes susceptibility genes.
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FPG = fasting plasma glucose; FBAT = family-based association test; FHS = Framingham Heart Study; GEE = generalized estimating equations; GWA = Genome-wide association; HbA1c = hemoglobin A1c; HOMA-IR = homeostasis model insulin resistance; HWE = Hardy Weinberg equilibrium; IBD = Identity-by-descent; ISI_0-120 = 0--120 min insulin sensitivity index; LD = Linkage disequilibrium; LOD = Log odds score; MAF = Minor allele frequency; SNP = Single nucleotide polymorphism;TFPG = 28-yr time-averaged FPG.
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